Lung cancer deaths in the national lung screening trial attributed to nonsolid nodules

Radiology

Volumn 281, Issue 2, 2016, Pages 589-596

  Yip, Rowena ^a   Yankelevitz, David F ^a   Hu, Minxia ^a,b   Li, Kunwei ^a,c   Xu, Dong Ming ^a   Jirapatnakul, Artit ^a   Henschke, Claudia I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSQUAMOUS CARCINOMA; CANCER MORTALITY; CANCER SCREENING; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; MULTIPLE CANCER; NEUROENDOCRINE TUMOR; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIGNET RING CARCINOMA; SMALL CELL LUNG CANCER; SQUAMOUS CELL LUNG CARCINOMA; VALIDATION STUDY; ADENOCARCINOMA; AGED; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EPIDEMIOLOGY; FEMALE; LUNG TUMOR; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; MULTIPLE PULMONARY NODULES; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; UNITED STATES; X-RAY COMPUTED TOMOGRAPHY;

ADENOCARCINOMA; AGED; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; MULTIPLE PULMONARY NODULES; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84979233844     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2016152333     Document Type: Review

References (26)

1. Sone S, Nakayama T, Honda T, et al. Longterm follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography. Lung Cancer 2007;58(3): 329-341.
2. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer 1995;75(12):2844-2852.
3. Henschke CI, Yankelevitz DF, Mirtcheva R, et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002;178(5): 1053-1057.
4. Carter D, Vazquez M, Flieder DB, et al. Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. Lung Cancer 2007;56(2):193-199.
5. Vazquez M, Carter D, Brambilla E, et al. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 2009;64(2):148-154.
6. Henschke CI, Yankelevitz DF, Yip R, et al. Lung cancers diagnosed at annual CT screening: volume doubling times. Radiology 2012;263(2):578-583.
7. Yankelevitz DF, Yip R, Smith JP, et al. CT screening for lung cancer: nonsolid nodules in baseline and annual repeat rounds. Radiology 2015;277(2):555-564.
8. Kazerooni EA, Austin JH, Black WC, et al. ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4). J Thorac Imaging 2014; 29(5):310-316.
9. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 2010;102(23):1771-1779.
10. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365(5):395-409.
11. Marcus PM, Gareen IF, Miller AB, et al. The National Lung Screening Trial's end point verification process: determining the cause of death. Contemp Clin Trials 2011; 32(6):834-840.
12. Commean PK, Rathmell JM, Clark KW, Maffitt DR, Prior FW. A query tool for investigator access to the data and images of the National Lung Screening Trial. J Digit Imaging 2015;28(4):439-447.
13. Yip R, Wolf A, Tam K, et al. Outcomes of lung cancers manifesting as nonsolid nodules. Lung Cancer 2016; 97: 35-42.
14. Kitamura H, Kameda Y, Nakamura N, et al. Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma: analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. Am J Surg Pathol 1996;20(5):553-562.
15. Wang JC, Sone S, Feng L, et al. Rapidly growing small peripheral lung cancers detected by screening CT: correlation between radiological appearance and pathological features. Br J Radiol 2000;73(873):930-937.
16. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005;23(14):3279-3287.
17. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc 2011;8(5):381-385.
18. Gierada DS, Pinsky P, Nath H, Chiles C, Duan F, Aberle DR. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. J Natl Cancer Inst 2014;106(11):dju284.
19. Henschke CI, Yip R, Yankelevitz DF, Smith JP; International Early Lung Cancer Action Program Investigators. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2013;158(4):246-252.
20. Yip R, Henschke CI, Yankelevitz DF, Smith JP. CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases. Radiology 2014;273(2):591-596.
21. Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 2004;231(1):164-168.
22. Naidich DP, Bankier AA, MacMahon H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013;266(1):304-317.
23. International Early Lung Cancer Action Program Protocol. http://www.ielcap.org/sites/default/files/I-ELCAP%20protocolv21-3-1-14.pdf. Accessed March 27, 2015.
24. Cho S, Yang H, Kim K, Jheon S. Pathology and prognosis of persistent stable pure ground-glass opacity nodules after surgical resection. Ann Thorac Surg 2013;96(4): 1190-1195.
25. Soda H, Nakamura Y, Nakatomi K, et al. Stepwise progression from ground-glass opacity towards invasive adenocarcinoma: long-term follow-up of radiological findings. Lung Cancer 2008;60(2):298-301.
26. Kakinuma R, Ohmatsu H, Kaneko M, et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr 2004;28(1): 17-23.